Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Piqray

Alpelisib

Open in the dashboard

Part D claims

1,318

Prescriptions dispensed, refills included

Drug cost

$28,126,397

Paid at the pharmacy, in all

Prescribers

100

With 11 or more claims of it

In 2024, Medicare Part D recorded 1,318 claims for Piqray (alpelisib) from 100 prescribers, at a total drug cost of $28.1 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 32 states and territories
Part D claims for Piqray by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 21 276 $5,961,101
TX 8 101 $2,165,083
FL 8 96 $2,172,724
IL 7 84 $1,772,575
PA 5 77 $1,746,081
NY 5 64 $1,390,719
CT 4 61 $1,427,663
GA 3 47 $1,028,121
AL 3 43 $885,774
MI 3 37 $692,247
MO 3 35 $743,066
MA 3 34 $578,307
IN 2 32 $695,692
KY 2 27 $551,288
MN 2 27 $537,919
The other 17 states and territories
State Prescribers Claims Drug cost
AZ 2 26 $520,942
UT 2 24 $521,632
LA 2 24 $503,233
OH 1 22 $472,827
WA 2 22 $487,310
NV 1 20 $356,868
SC 1 15 $318,917
TN 1 15 $318,527
MT 1 14 $189,125
NJ 1 13 $285,222
NE 1 13 $283,942
AR 1 12 $260,239
MD 1 12 $258,438
VA 1 12 $304,749
DE 1 11 $233,033
CO 1 11 $227,210
ME 1 11 $235,823

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 10 of 10
Part D claims for Piqray by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 63 844 $18,027,399
Medical Oncology 19 237 $5,106,739
Nurse Practitioner 6 75 $1,499,334
Internal Medicine 3 45 $994,454
Physician Assistant 3 36 $750,225
Hematology 2 28 $557,900
Hospitalist 1 15 $323,981
Diagnostic Radiology 1 14 $289,937
Allergy/ Immunology 1 13 $332,772
Pharmacist 1 11 $243,655

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Vida Jahangiri Internal Medicine PA 23 $552,922 None on record
Daniel Silbiger Hematology-Oncology OH 22 $472,827 None on record
Brian Byrne Hematology-Oncology CT 20 $441,368 None on record
Anuradha Thummala Hematology-Oncology NV 20 $356,868 None on record
Wenli Gao Hematology-Oncology CT 19 $504,087 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for alpelisib

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record